Press Releases about Incyte Corp
![](https://mms.businesswire.com/media/20230326005073/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20230323005785/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
From Incyte
Via Business Wire
![](https://mms.businesswire.com/media/20230322005618/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20230318005041/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20230318005040/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20230314006043/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20230306005672/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20230303005316/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20230223006046/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20230216005010/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20230210005205/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20230207005303/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20230124005025/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20230117005125/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
Incyte to Report Fourth Quarter and Year-End 2022 Financial Results
January 17, 2023
From Incyte
Via Business Wire
![](https://mms.businesswire.com/media/20221215005007/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20221211005037/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
Incyte’s Novel Mutant CALR Antibody Unveiled at ASH 2022 Plenary Scientific Session
December 11, 2022
From Incyte
Via Business Wire
![](https://mms.businesswire.com/media/20221210005030/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20221202005043/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20221117005001/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20221106005116/en/1627174/5/Mirati_Logo_Purple_JPG_File.jpg)
![](https://mms.businesswire.com/media/20221107005169/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20221103005878/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20221101005407/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
November 01, 2022
From Incyte
Via Business Wire
![](https://mms.businesswire.com/media/20221019006152/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20221011005007/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20221004005151/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20221003005269/en/1589087/4/Villaris_logo.jpg)
![](https://mms.businesswire.com/media/20220826005244/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20220824005066/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20220823005001/en/1078784/5/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.